Bin‐Yan Zhong

机构：Chinese Academy of Sciences, Zhejiang Cancer Hospital, Zhongshan Hospital, Hangzhou Cancer Hospital · ORCID：0000-0001-9716-1211

发表论文 113 篇 · 总被引 2173 次 · h-index 23

代表论文

Combination locoregional and systemic therapies in hepatocellular carcinoma (2025 · The Lancet. Gastroenterology & hepatology · 被引 87)
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204) (2025 · Hepatology · 被引 9)
99mTc/90Y radiolabeled biodegradable gel microspheres for lung shutting fraction assessment and radioembolization in hepatocellular carcinoma theranostics (2024 · Materials Today Bio · 被引 6)
Transarterial intervention therapy plus systemic therapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis (2025 · EngMedicine · 被引 5)
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study (2026 · EClinicalMedicine · 被引 4)
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First‐Line Treatment for Advanced Hepatocellular Carcinoma (2026 · Alimentary Pharmacology & Therapeutics · 被引 3)